Amarin Corporation plc (Nasdaq: AMRN) announced that the number of patients enrolled in the company's REDUCE-IT cardiovascular outcomes study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE